Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2521 (LINC02521)
- Target
- LINC02521
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) family
01
Overview
Long intergenic non-protein coding RNA 2521 (LINC02521) is a human lincRNA gene, defined as an autonomously transcribed non-coding RNA longer than 200 nucleotides that does not overlap a coding gene[1][3][5][7]. LincRNAs, including LINC02521, regulate gene expression through diverse mechanisms such as chromatin remodeling, RNA-protein scaffolding, stabilization of RNAs, and enhancer-like activity[5][7]. Unlike protein-coding genes, lincRNAs predominantly modulate cellular function by influencing the expression of other genes and by forming ribonucleoprotein complexes, often in a sequence- or structure-dependent manner. No evidence currently supports LINC02521 as a druggable target or biomarker in human disease[1][3].
- Other names
- LINC02521Long intergenic non-protein coding RNA 2521
02
Biological functions
Regulation of chromatin structure and genome architectureRNA stabilizationTranscription regulation, including enhancer-associated activityPotential to regulate neighboring gene expression (often in a tissue-specific manner)
03
Disease associations
Other (No specific disease role described for LINC02521)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2521 (LINC02521).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2521 (LINC02521).